newsfilter
← Latest News
Business Wire·

Stoke Therapeutics Appoints Thomas McCauley, Ph.D., as Chief Scientific Officer

–Dr. McCauley brings more than 25 years of experience building high-performing R&D organizations and translating early scientific discoveries into new medicines for people with severe diseases– Stoke